Tarsus Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
/ 
Frequently asked questions
To buy Tarsus Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Tarsus Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Tarsus Pharmaceuticals Inc. is TARS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Tarsus Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Tarsus Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Tarsus Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Tarsus Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Tarsus Pharmaceuticals Inc..